Publications by authors named "MD Barker"

Claim this Profile
H
Home-based primary care-mental health integration in the Veterans Health Administration: An updated evaluation of practice patterns.
Shahrzad Mavandadi, Julie Loebach Wetherell, Marie D Barker, Pamela L Steadman-Wood, Paula J Harrington

Psychol Serv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Covalent targeting of non-cysteine residues in PI4KIIIβ.
Brett Cosgrove, Emma K Grant, Sophie Bertrand, Kenneth D Down, Don O Somers, Michael D Barker

RSC Chem Biol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence that all Sorsby's fundus dystrophy mutations cause TIMP3 dimerization resulting in impaired inhibition of VEGFR2.
Fatimah A Alsaffar, Ahmed H Mujamammi, Mohammed S K Aldughaim, Martin J H Nicklin, Michael D Barker

Genes Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the effects of the core nitrogen atom configuration on the thermodynamic solubility of 6,5-bicyclic heterocycles.
Brett Cosgrove, Kenneth Down, Sophie Bertrand, Nicholas C O Tomkinson, Michael D Barker

Bioorg Med Chem Lett· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coupling of a Novel TIMP3 Peptide to Carboxypeptidase G2 for Pro-Drug Activation at the Tumour Site.
Mohammed S Aldughaim, Fatimah Alsaffar, Michael D Barker

Molecules· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific Targeting of PEGylated Liposomal Doxorubicin (Doxil) to Tumour Cells Using a Novel TIMP3 Peptide.
Mohammed S Aldughaim, Munitta Muthana, Fatimah Alsaffar, Michael D Barker

Molecules· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating Deficits in Auditory Processing Abilities.
Matthew D Barker, Candace Bourland Hicks

Lang Speech Hear Serv Sch· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of potent and selective Spleen Tyrosine Kinase inhibitors for the topical treatment of inflammatory skin disease.
Michael D Barker, John Liddle, Francis L Atkinson, David Matthew Wilson, Marion C Dickson

Bioorg Med Chem Lett· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cortical Auditory-Evoked Potential and Behavioral Evidence for Differences in Auditory Processing between Good and Poor Readers.
Matthew D Barker, Abin Kuruvilla-Mathew, Suzanne C Purdy

J Am Acad Audiol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An initial investigation into the validity of a computer-based auditory processing assessment (Feather Squadron).
Matthew D Barker, Suzanne C Purdy

Int J Audiol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors.
Neil S Garton, Michael D Barker, Rob P Davis, Clement Douault, Edward Hooper-Greenhill

Bioorg Med Chem Lett· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate Derivatives.
Susan M Westaway, Alex G S Preston, Michael D Barker, Fiona Brown, Jack A Brown

J Med Chem· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives.
Susan M Westaway, Alex G S Preston, Michael D Barker, Fiona Brown, Jack A Brown

J Med Chem· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application and clinical utility of the Glasgow Coma Scale over time: a study employing the NIDRR traumatic brain injury model systems database.
Marie D Barker, John Whyte, Christopher R Pretz, Mark Sherer, Nancy Temkin

J Head Trauma Rehabil· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.
Huw D Lewis, John Liddle, Jim E Coote, Stephen J Atkinson, Michael D Barker

Nat Chem Biol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enantioselective catalytic desymmetrization of maleimides by temporary removal of an internal mirror plane and stereoablative over-reduction: synthesis of (R)-pyrrolam A.
Barrie J Marsh, Harry Adams, Mike D Barker, Ibrahim U Kutama, Simon Jones

Org Lett· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A peptide derived from TIMP-3 inhibits multiple angiogenic growth factor receptors and tumour growth and inflammatory arthritis in mice.
Yung-Yi Chen, Nicola J Brown, Rita Jones, Claire E Lewis, Ahmed H Mujamammi, Michael D Barker

Angiogenesis· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-Phenyl-7-azaindoles as potent, selective and bioavailable IKK2 inhibitors demonstrating good in vivo efficacy.
John Liddle, Paul Bamborough, Michael D Barker, Sebastien Campos, Chun-Wa Chung

Bioorg Med Chem Lett· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor.
John Liddle, Francis L Atkinson, Michael D Barker, Paul S Carter, Neil R Curtis

Bioorg Med Chem Lett· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lentiviral shRNA knock-down of ADAMTS-5 and -9 restores matrix deposition in 3D chondrocyte culture.
Teresa C Coughlan, Aileen Crawford, Mary B Goldring, Paul V Hatton, Michael D Barker

J Tissue Eng Regen Med· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palladium-catalyzed [1,3]-O-to-C rearrangement of pyrans toward functionalized cyclohexanones.
Julien C R Brioche, Thomas A Barker, David J Whatrup, Michael D Barker, Joseph P A Harrity

Org Lett· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Embedded indices of effort in the repeatable battery for the assessment of neuropsychological status (RBANS) in a geriatric sample.
Marie D Barker, Michael David Horner, David L Bachman

Clin Neuropsychol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration.
Michael D Woodrow, Stuart P Ballantine, Michael D Barker, Beth J Clarke, John Dawson

Bioorg Med Chem Lett· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitors.
John Liddle, Paul Bamborough, Michael D Barker, Sebastien Campos, Rick P C Cousins

Bioorg Med Chem Lett· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetic resolution of racemic pyrrolidine-2,5-diones using chiral oxazaborolidine catalysts.
Mike D Barker, Rachel A Dixon, Simon Jones, Barrie J Marsh

Chem Commun (Camb)· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis